Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-81,349
Closed -$602K 1006
2024
Q3
$602K Buy
81,349
+4,599
+6% +$38.7K ﹤0.01% 588
2024
Q2
$615K Buy
76,750
+10,803
+16% +$96.5K ﹤0.01% 549
2024
Q1
$768K Buy
65,947
+13,491
+26% +$149K 0.01% 542
2023
Q4
$586K Sell
52,456
-3,215
-6% -$29.6K ﹤0.01% 580
2023
Q3
$860K Buy
55,671
+2,109
+4% +$35.4K 0.01% 503
2023
Q2
$1.01M Buy
53,562
+20,250
+61% +$356K 0.01% 489
2023
Q1
$507K Buy
33,312
+1,729
+5% +$22.5K ﹤0.01% 590
2022
Q4
$402K Buy
+31,583
New +$284K ﹤0.01% 674
2022
Q2
Sell
-21,026
Closed -$79K 1054
2022
Q1
$79K Sell
21,026
-2,443
-10% -$15.7K ﹤0.01% 831
2021
Q4
$307K Sell
23,469
-1,144
-5% -$18.1K ﹤0.01% 827
2021
Q3
$482K Sell
24,613
-1,808
-7% -$33K ﹤0.01% 507
2021
Q2
$494K Sell
26,421
-9,538
-27% -$213K ﹤0.01% 520
2021
Q1
$852K Buy
35,959
+28
+0.1% +$646 0.01% 415
2020
Q4
$876K Buy
+35,931
New +$919K 0.01% 400

Other funds holding ETNB

ALPS Advisors's ETNB Position: Q4 2024 in Review

ALPS Advisors sold out of 89bio (ETNB) in Q4 2024, closing a stake of 81,349 shares — an estimated $602K sold.

ALPS Advisors first reported a position in ETNB in Q4 2020 and held it in 14 quarters. The position peaked at $1.01M in Q2 2023. 155 funds tracked by Wall St. Rank hold ETNB as of Q4 2024.

  • ALPS Advisors reported no remaining 89bio position as of Q4 2024 after selling out during the quarter.
  • ALPS Advisors sold 81,349 89bio shares in Q4 2024, an estimated $602K.
  • ALPS Advisors first reported a position in 89bio in Q4 2020 and held it in 14 quarters.
  • ALPS Advisors's 89bio position peaked at $1.01M in Q2 2023.
  • 155 funds tracked by Wall St. Rank held 89bio as of Q4 2024.

Based on ALPS Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.